20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP2018L | GIP (human) acetate | GIP (human) acetate(100040-31-1 Free base) | IGF-1R |
GIP (human) acetate is a stimulator of glucose-dependent insulin secretion and a weak inhibitor of gastric acid secretion. GIP (human) acetate plays a vital role in lipid metabolism and the development of obesity. | |||
TP2017L | GIP (1-39) acetate | GIP (1-39) acetate(725474-97-5 Free base) | Others |
GIP (1-39) acetate is a gastric inhibitory peptide (GIP) purified from porcine intestine and stimulates insulin secretion. | |||
TP2020L | [Pro3]-GIP (Mouse) acetate | Others | |
[Pro3]-GIP (Mouse) acetate is mouse [Pro3]-GIP. [Pro3]-GIP is a GIP receptor antagonist. | |||
T37588L | GIP (1-30) amide, porcine acetate | IGF-1R | |
GIP (1-30) amide, porcine acetate is an agonist of fully glucose-dependent insulinotropic polypeptide (GIP) receptor. GIP (1-30) amide, porcine acetate can weakly inhibit gastric acid secretion and strongly stimulate ins... | |||
TP2018 | GIP, human | GIP (human) | |
Potent insulinotropic hormone synthesized by duodenal K-cells. High affinity GIP receptor agonist (EC50 = 0.81 nM) that inhibits gastric acid secretion and stimulates pancreatic insulin release in response to glucose. Al... | |||
TP1584 | GIP (1-30) amide,human | GIP (1-30) amide (Human) | |
GIP (1-30) amide (Human) is an insulin-dependent glucose-dependent polypeptide.The sugar-dependent insulin polypeptide (GIP) is an insulin secreting hormone, which can stimulate the secretion of insulin and reduce the oc... | |||
T37589L | GIP (3-42), human acetate | GIP (3-42), human acetate(1802086-25-4 Free base) | IGF-1R |
GIP (3-42), human acetate is an antagonist of a glucose-dependent insulinotropic polypeptide (GIP) receptor and regulates insulin secretion and GIP metabolism in vivo. | |||
TP2020 | [Pro3]-GIP (Mouse) | ||
GIP receptor antagonist (IC50 = 2.6μM). Inhibits GIP-stimulated insulin release from pancreatic β cells in vitro. In ob/ob mice, blocks the effects of GIP on insulin release and plasma glucose levels. Also improves intra... | |||
TP2017 | GIP (1-39) | ||
Endogenous truncated form of the incretin hormone GIP. More potent at stimulating glucose-dependent insulin secretion from rat pancreatic β-cells than GIP. | |||
TP2021 | [Pro3]-GIP (Rat) | ||
High affinity rat GIP receptor partial agonist (Kd = 13 nM). Increases cAMP accumulation in COS-7 cells transfected with rat GIP receptor, while also acting as a competitive antagonist of GIP. | |||
T37589 | GIP (3-42), human | Gastric Inhibitory Polypeptide (3-42) (human) | IGF-1R |
GIP (3-42), human (Gastric Inhibitory Polypeptide (3-42) (human)) is a peptide that acts as a glucose-dependent proinsulinotropic polypeptide (GIP) receptor antagonist and regulates insulin secretion and the metabolic ef... | |||
T37588 | GIP (1-30) amide, porcine | ||
This GIP fragment has potent insulinotropic activity in the isolated, perfused rat pancreas but greatly reduced somatostatinotropic activity in the isolated perfused rat stomach. The site responsible for insulinotropic a... | |||
TP1566 | GIP (1-30) amide (Human) (TFA) | ||
GIP (1-30) amide (Human) TFA is a glucose-dependent insulinotropic polypeptide fragment. Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone that stimulates insulin secretion and reduces postprandia... | |||
T37601 | GIP (1-30) amide, porcine TFA | ||
GIP (1-30) amide, porcine TFA is a high-affinity full agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor, having a similar potency as the native GIP(1-42) [1]. Furthermore, GIP (1-30) amide, porci... | |||
TP2019 | [D-Ala2]-GIP (human) | ||
Highly potent GIP receptor agonist (EC50 = 630 ± 119 pM). Displays equivalent cAMP stimulating properties and improved resistance to enzymatic degradation compared to native GIP in cells expressing wild type GIP receptor... | |||
T76313 | (Pro3) GIP, human | ||
(Pro3) GIP, human ((Pro3) Gastric Inhibitory Peptide, human) is a stable and specific full agonist for the human GIP receptor (hGIPR) with a high binding affinity, represented by K i / K d values of 0.90 nM. It shows eff... | |||
T82316 | GIP, rat TFA | ||
GIP, rat TFA (glucose-dependent insulinotropic polypeptide), a 42-amino acid peptide secreted by K cells in the duodenum and jejunum, promotes insulin release from pancreatic beta cells, supports beta cell proliferation,... | |||
T82317 | GIP, rat | ||
GIP (rat) (Glucose-dependent Insulinotropic Polypeptide), also known as Gastric Inhibitory Polypeptide, is a biologically active 42-amino acid peptide secreted by the K cells of the duodenum and jejunum following food co... | |||
T75757 | GIP, human TFA | ||
GIP, human TFA, a 42-amino acid peptide hormone, functions as a glucose-dependent insulin secretion stimulator and a weak gastric acid secretion inhibitor. Released from intestinal K cells following nutrient ingestion, i... | |||
T76041 | GIP (1-30) amide,human acetate | ||
GIP (1-30) amide, human acetate is a fragment of glucose-dependent insulinotropic polypeptide (GIP), an incretin hormone that plays a crucial role in stimulating insulin secretion and mitigating postprandial glycemic exc... |